Steroid Tapering for Chemotherapy-Induced Pneumonitis

Grade-Based Tapering Approach

The European Society for Medical Oncology recommends tapering corticosteroids over 4-6 weeks for mild-to-moderate chemotherapy-induced pneumonitis (grade 1-2) and over 6 weeks or longer for severe cases (grade 3-4), with careful monitoring for relapse during the taper, particularly when reaching ≤10 mg prednisone daily 1, 2
For grade 1-2 pneumonitis, start with prednisone 1-2 mg/kg orally daily after ruling out infection, and taper over 4-6 weeks once clinical and radiographic improvement is documented 1, 2
Assess patients clinically every 2-3 days initially, with repeat imaging for grade 2 cases, and monitor weekly with history, physical examination, and pulse oximetry during the taper 3, 4

Monitor patients weekly with symptom assessment and oxygen saturation checks during the taper 4, 5
Obtain repeat chest imaging if symptoms worsen or fail to improve 4

The American College of Clinical Pharmacology recommends starting proton pump inhibitor therapy for GI prophylaxis in all patients receiving steroids for grade 2-4 pneumonitis 5
Consider Pneumocystis jiroveci pneumonia prophylaxis for patients receiving ≥20 mg methylprednisolone equivalent for ≥4 weeks 4, 5
Initiate calcium and vitamin D supplementation with prolonged steroid use 4, 5

Second-line options for steroid-refractory pneumonitis include cyclophosphamide, infliximab, or mycophenolate mofetil 1, 2

Always rule out infection before starting or escalating immunosuppression, ideally with bronchoscopy and bronchoalveolar lavage 3, 5
Do not restart chemotherapy until steroid dose is ≤10 mg prednisone daily (for grade 1-2 cases where rechallenge is considered) 3
Avoid prolonged courses beyond what is necessary, as infection risk increases significantly with extended steroid use 5